FOXO3 and Parkinson disease: This suggests that dopaminergic neurons are particularly vulnerable to changes in FOXO3 activity in the substantia nigra, according to Pino et al. Furthermore, exposure to manganese causes patients to exhibit clinical symptoms that resemble PD.